Survey results show level of concordance between patients with CRC and their caregivers when rating care quality. The survey also measured whether clinical or demographic factors influenced the agreement between patient-caregiver pairs.
The uptick in early-onset disease began in the mid-1990s among most high-income countries with long-term data. In younger adults, the steepest increases were seen in South Korea and New Zealand (average annual percent change, 4.2 and 4.0, respectively).
For patients with advanced/metastatic colorectal cancer (mCRC), greater total physical activity is not associated with longer overall survival, but it may prolong progression-free survival and lower the risk for treatment-related toxicities.
The cost per colonoscopy, including purchase, maintenance, and reprocessing costs, varies from $188.64 to $501.16, with higher costs at low-volume centers.
Mvasi (bevacizumab-awwb), a biosimilar to Avastin (bevacizumab), and Kanjinti (trastuzumab-anns), a biosimilar to Herceptin (trastuzumab) have been made available by Amgen and Allergan.
The researchers found that the first postoperative bowel movement occurred 8.9 hours earlier in the group that received coffee (65.2 versus 74.1 hours; hazard ratio, 1.67). Patients who received coffee also had shorter hospital stays (six versus seven days).
Researchers sought to identify missed opportunities for diagnosis of colorectal cancer in primary care that lead to referral delays and emergency diagnoses in younger patients.
There is a close association between intolerance to early oral feeding after colorectal surgery and postoperative complications. Patients should be closely monitored and not discharged until complications have been ruled out.
For some cancers (e.g., lung cancer and melanoma), there were differences in trends in the oldest age groups compared with adults aged 65 to 84 years, with elevated risks in the oldest old.
The researchers found that the likelihood of presenting with abdominal pain and via an emergency was increased for young patients, and they had the lowest percentage of early-stage cancer.
Study concludes that few of the associated risk factors are modifiable and that clinicians should stress possible outcomes related to urinary dysfunction prior to patients receiving treatment for rectal cancer.
The prescribing information for Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid; Ferring) has been updated to include use in pediatric patients ≥9 years old for cleansing of the colon as a preparation for colonoscopy.
Researchers investigated whether increasing colorectal cancer incidence among younger individuals is associated with an increase in disease occurrence or with increased detection as a result of more colonoscopies being performed over time.
ESGE 2019 update on bowel preparation for colonoscopy incorporates new evidence into the clinical recommendations to be adopted in routine and specific scenarios.
From 2000 to 2015, colonoscopy rates increased among those aged 45 to 54 years, while colorectal cancer incidence increased among those aged 40 to 54 years.
Findings provide support for current guidelines, which recommend repeat lower endoscopy within 3 years of a diagnosis of advanced adenomas and large serrated polyps.
The incidence of early onset colorectal cancer per 100,000 people increased from 6.7 during 1995-1996 to 11.5 during 2014-2015 for residents of the state of WA.
Primary care patients who were not up-to-date with colorectal cancer screening received a mailed invitation to complete an enclosed fecal immunochemical test or schedule colonoscopy.
